ISSN:

Journal Home

Multiple Sclerosis and Demyelinating Disorders Q4 Unclaimed

BioMed Central Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Multiple Sclerosis and Demyelinating Disorders is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 2. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on multiple sclerosis, neuromyelitis optica, demyelinating diseases, diseases of the central nervous system, clinical care. It has an SJR impact factor of 0,131 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,131.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Immunology (Q4) Immunology and Allergy (Q4) Immunology and Allergy (Q4) Neurology (Q4) Neurology (clinical) (Q4) Neurology (clinical) (Q4)

Price

1507 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Multiple Sclerosis and Demyelinating Disorders

0,131

SJR Impact factor

2

H Index

0

Total Docs (Last Year)

1

Total Docs (3 years)

0

Total Refs

0

Total Cites (3 years)

1

Citable Docs (3 years)

0

Cites/Doc (2 years)

0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Q4
HLA Q4
Current Immunology Reviews Q4
Case Reports in Immunology Q4
Immunohematology Q4

Compare this journals

Aims and Scope

Multiple sclerosis Neuromyelitis optica Demyelinating diseases Diseases of the central nervous system Clinical care